Discriminative stimulus properties of cocaine: Enhancement by β- adrenergic receptor antagonists

Psychopharmacology

Volumn 131, Issue 3, 1997, Pages 307-312

  Kleven, Mark S ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Adrenergic receptors; ( ) Propranolol; Betaxolol; Cocaine; Dose versus dose discrimination; Drug discrimination; ICI 118,551; Nadolol; Tertatolol

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETAXOLOL; BRIMONIDINE; CIRAZOLINE; COCAINE; EFAROXAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NADOLOL; PROPRANOLOL DERIVATIVE; TERTATOLOL;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; DATA ANALYSIS; DOPAMINE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BENZOFURANS; BETAXOLOL; COCAINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DRUG SYNERGISM; IMIDAZOLES; MALE; NADOLOL; NARCOTICS; PROPANOLAMINES; PROPRANOLOL; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; THIOPHENES;

EID: 0030740630     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050297     Document Type: Article

References (28)

1. 2-selective adrenoceptor antagonist (ICI118551). J Cardiovasc Pharmacol 5: 430-437
2. Booze RM, Crisostomo EA, Davis JN (1989) Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig. J Pharmacol Exp Ther 249: 911-920
3. 2C receptors. J Pharmacol Exp Ther 274: 1414-1424
4. Colpaert FC, Janssen PAJ (1982) Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination. Arch lnt Pharmacodyn Ther 258: 283-299
5. Colpaert FC, Janssen PAJ (1986) Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination. Psychopharmacology 90: 222-228
6. Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10: 535-546
7. Conway PG, Tejani-Butt S, Brunswick DJ (1987) Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo. J Pharmacol Exp Ther 241: 755-762
8. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104: 177-180
9. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281: 81-88
10. Goldberg SR, Gonzalez FA (1976) Effects of propranolol on behavior maintained under fixed-ratio schedules of cocaine injection or food presentation in squirrel monkeys. J Pharmacol Exp Ther 198: 626-634
11. Grenhoff J, Svensson TH (1989) Clonidine modulates dopamine cell firing in the rat ventral tegmental area. Eur J Pharmacol 165: 11-18
12. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233: 79-84
13. Harris GC, Hedaya MA, Pan WJ, Kalivas P (1996) β-Adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology 14: 195-204
14. Hubert JJ (1984) Bioassay. Kendall/Hunt, Dubuque, Iowa
15. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199: 649-661
16. Koek W, Kleven MS, Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: characterisation of intermediate levels of drug lever selection. Behav Pharmacol 6: 590-600
17. Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32: 337-362
18. Marien M, Lategan A, Colpaert F (1994) Noradrenergic control of striatal dopaminc release. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson's disease. CRC Press, London,pp 139-158
19. Middlemiss DN (1986) Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists. Eur J Pharmacol 120: 51-56
20. 2-adrenergic receptors. Life Sci 57: 327-332
21. 1A) receptor antagonist in rat brain. J Pharmacol Exp Ther 265: 739-744
22. Reith MEA, Meisler BE, Sershen H, Lajtha A (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35: 1123-1129
23. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112: 93-99
24. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275: 53-62
25. 1A selective agonists. Eur J Pharmacol 128: 295-298
26. Tallarida RJ, Murray RG (1987) Manual of pharmacological calculations with computer programs. Springer Verlag, New York
27. Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51: 687-692
28. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270: 1041-1048